
Your daily dose of clinical news you may have missed.

The influenza vaccine may offer a protective effect against hospitalization for respiratory syncytial virus in young children, suggest data from Australia.

Is BMI or body fat a better estimate of obesity?; spoiler: older women do drink ETOH; USPSTF vs ACC/AHA; plus no more opioids for LBP and a primer on migraine meds.

The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.

Your daily dose of clinical news you may have missed.
The 72-year-old woman says the back pain came on earlier in the evening without injury or heavy lifting and radiates slightly to her left leg. What does the MRI show?

Children and adolescents who reported facing more racial discrimination had a higher BMI and waist circumference, according to new data.

In Israel, where 60% of adults are overweight, new research prompts investigators to suggest that % body fat should replace BMI as the gold standard measure of obesity.

Your daily dose of clinical news you may have missed.

An overview of common headache conditions and treatments for primary care clinicians, here.

Binge drinking among women going through menopause has been on the rise, research indicates, making clinical inquiry in this population particularly important.

In a recent comparison of guideline recommendations for initiating statin therapy in primary prevention, researchers found significant differences in the numbers who would benefit.

Underestimation of weight status increased while overestimation decreased during the last 2 decades, according to results from a study of over 745 000 adolescents.

In patients with NAFLD, type 2 diabetes was found to be an independent predictor of both hepatic decompensation and incident HCC, according to meta-analysis authors. .

Your daily dose of clinical news you may have missed.
The importance of avoiding judgement, monitoring behavior, and cardiovascular risk prevention in primary care are discussed, here.

The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.

Your daily dose of clinical news you may have missed.

In the post COVID-19 pandemic health care emergency era, private and public insurance entities will continue full coverage of the shots - but what about the uninsured?

In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.